Latest myasthenia gravis Stories

2011-07-21 07:11:00

SAN MATEO, Calif., July 21, 2011 /PRNewswire/ -- Merz Aesthetics today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved XEOMIN® (incobotulinumtoxinA) for the temporary improvement in the appearance of moderate to severe glabellar lines, or frown lines between the eyebrows, in adult patients. Photos/Multimedia Gallery Available: http://www.news2know.net/mnr/merz-aesthetics/xeomin.php "The FDA approval of XEOMIN is a significant milestone for Merz...

2011-06-02 22:14:41

Improving the strength of patients with Myasthenia Gravis, a disease characterized by varying degrees of muscular weakness, is the goal of a new study being conducted at Baylor College of Medicine.

2011-06-02 14:00:00

NEW YORK, June 2, 2011 /PRNewswire/ -- Who: Fernando Ferrer, former NYC mayoral candidate and MG patient, will be joining hundreds of walkers at the 2011 TriState MG Walk on Sunday, June 12 at Riverside Park in Manhattan.

2011-04-18 10:56:00

NEW YORK, April 18, 2011 /PRNewswire/ -- What: The MG Walk is a new signature fundraising campaign designed to provide hope for the thousands of families forced to face the challenges caused by myasthenia gravis.

2011-03-30 07:11:00

GREENSBORO, N.C., March 30, 2011 /PRNewswire/ -- Merz Pharmaceuticals, LLC announced today that the Centers for Medicare and Medicaid Services (CMS) has granted a unique Healthcare Common Procedure Coding System (HCPCS) billing code, Q2040, for Xeomin® (incobotulinumtoxinA).

2011-03-08 07:11:00

GREENSBORO, N.C., March 8, 2011 /PRNewswire/ -- Merz Pharmaceuticals today announced the launch of two programs to provide financial assistance to patients for their treatment with Xeomin® (incobotulinumtoxinA).

2010-10-05 07:11:00

GREENSBORO, N.C., Oct. 5 /PRNewswire/ -- Merz Pharmaceuticals today announced that Xeomin® (incobotulinumtoxinA), a new botulinum toxin type A for the treatment of adults with cervical dystonia (CD)or blepharospasm, is now commercially available in the U.S. XEOMIN was approved by the U.S.

2009-11-13 16:07:00

HOUSTON, Nov. 13 /PRNewswire/ -- Plagued by a growing weakness that left her unable to walk, talk and even take a normal breath, 11-year-old Iraqi Aram Ali was a shell of the bright little girl she used to be. No one could figure out what was wrong.

Word of the Day
  • The word or words serving to define another word or expression, as in a dictionary entry.
The word 'definiens' comes from the Latin word 'definire', 'to define'.